







B.C. Reg. 417/2008

M310/2008


Deposited December 12, 2008

effective April 1, 2009





This consolidation is current to March 5, 2024.




Link to consolidated regulation (PDF)






Link to Point in Time




Health Professions Act


Pharmacists Regulation

[Last amended June 1, 2023 by B.C. Reg. 111/2023]





Definitions




1


In this regulation:


"Act"
means the

Health Professions Act

;


"college"
means the College of Pharmacists of British Columbia continued under
section 15.1 of the Act;


"compound"
means




(a)

in respect of a drug, to mix with one or more other ingredients, and




(b)

in respect of a therapeutic diet, to mix 2 or more appropriate
ingredients;


"device"
has the same meaning as in the

Pharmacy Operations and Drug Scheduling Act

;


"dispense"
has the same meaning as in the

Pharmacy Operations and Drug Scheduling Act

;


"drug"
has the same meaning as in the

Pharmacy Operations and Drug Scheduling Act

;



"Drug Schedules Regulation"

means the Drug Schedules Regulation, B.C. Reg. 9/98;



"medical assistance in dying"

means the following:




(a)

the administration of a substance




(i)

by a medical practitioner or a nurse practitioner to a person who
requests the substance, and




(ii)

that is intended to cause the death of the person who requested the
substance;




(b)

the prescription or provision of a substance




(i)

by a medical practitioner or a nurse practitioner to a person who
requests the substance, and




(ii)

that the person who requested the substance may administer to himself
or herself for the purpose of causing his or her own death;



"practice of pharmacy"

means the health profession in which a person provides the services of




(a)

identifying and assessing drug-related and device-related problems and
taking action to prevent or resolve those problems,




(a.1)

promoting health and preventing and treating diseases, disorders and
conditions through drug therapy,




(b)

monitoring drug therapy and advising on therapeutic values, contents
and hazards of drugs and devices, and




(c)

compounding and dispensing drugs and devices;


"prescribe"
means to issue a "prescription" as defined in the

Pharmacy Operations and Drug Scheduling Act

;


"sell"
has the same meaning as in the

Pharmacy Operations and Drug Scheduling Act

;


"substance"
means a drug that is not specified in Schedule I, IA
or II of the Drug Schedules Regulation.


[am. B.C. Regs. 234/2009, s. 1; 201/2016, Sch. 2, s. 1; 111/2023, App.
1, ss. 1 and 2.]






Reserved titles




2


The following titles are reserved for exclusive use by registrants:




(a)

apothecary;




(b)

druggist;




(c)

pharmacist;




(d)

pharmaceutical chemist;




(e)

pharmacy technician.

[am. B.C. Reg. 211/2010.]





Scope of practice




3


A registrant may practise the health profession of the practice of
pharmacy.






Restricted activities




4

(1)


A registrant in the course of practising the health profession of the
practice of pharmacy may do any of the following:




(a)

prescribe, for the purpose of contraception or emergency
contraception, a drug specified in Schedule I of the Drug
Schedules Regulation;




(a.1)

make a diagnosis identifying, as the cause of the signs or symptoms of
an individual, a disease, disorder or condition that is shown in
Column 1 of Schedule A, if all of the following conditions
are met:




(i)

the disease, disorder or condition, in the form indicated by the
individual's signs and symptoms,




(A)

presents a low risk of masking an underlying disease, disorder or
condition, and




(B)

can be readily diagnosed without the need for laboratory or imaging
tests;




(ii)

the individual's signs or symptoms can be reasonably expected to
resolve with only short-term or episodic treatment;




(a.2)

for the purpose of treating a disease, disorder or condition diagnosed
under paragraph (a.1), prescribe a drug that is




(i)

specified in Schedule I of the Drug Schedules Regulation, and




(ii)

within a drug category shown opposite the disease, disorder or
condition in Column 2 of Schedule A of this regulation;




(b)

compound a drug specified in Schedule I, IA, or II of the Drug
Schedules Regulation;




(c)

dispense a drug specified in Schedule I, IA, or II of the Drug
Schedules Regulation;




(c.1)

in respect of a drug specified in Schedule I, IA or II of the
Drug Schedules Regulation or a substance,




(i)

administer the drug or substance by intradermal, intramuscular or
subcutaneous injection or intranasally, or




(ii)

administer the drug or substance by any method for the purpose of
treating anaphylaxis arising from administering a drug or substance by
intradermal, intramuscular or subcutaneous injection or intranasally,
as described in subparagraph (i);




(d)

if nutrition is administered enterally or parenterally,




(i)

select appropriate ingredients for a therapeutic diet,




(ii)

compound a therapeutic diet, or




(iii)

dispense a therapeutic diet.




(2)

Only a registrant may provide a service of the health profession of
the practice of pharmacy as set out in this regulation if, on the day
before this section comes into force, the provision of the same
service by anyone other than a person authorized under the
Pharmacists, Pharmacy Operations and Drug Scheduling Act was
prohibited.


[am. B.C. Regs. 234/2009, s. 2; 256/2009; 225/2015; 111/2023, App. 1,
s. 3.]






Limits or conditions on services and restricted activities




4.1

(1)


A registrant may perform an activity described in
section 4 (1) (a), (a.1) or (a.2) only if




(a)

standards, limits and conditions have been established, under
section 19 (1) (k) or (l) of the Act, respecting




(i)

the making of diagnoses for the purposes of
section 4 (1) (a.1), and




(ii)

the prescribing, by registrants, of contraceptives and emergency
contraceptives, and of drugs referred to in Schedule A, and




(b)

the standards, limits and conditions described in paragraph (a)
are established on the recommendation of a committee that




(i)

is established under section 19 (1) (t) of the Act,




(ii)

has the duty and power to develop, review and recommend those
standards, limits and conditions, and




(iii)

includes at least one medical practitioner who is confirmed by the
College of Physicians and Surgeons of British Columbia as suitable to
be a member of the committee.




(1.1)

A registrant may perform an activity described in
section 4 (1) (c.1) only if




(a)

standards, limits and conditions have been established, under
section 19 (1) (k) or (l) of the Act, respecting the
administering of the drug or substance by registrants,




(b)

the standards, limits and conditions described in paragraph (a)
are established on the recommendation of a committee that




(i)

is established under section 19 (1) (t) of the Act, and




(ii)

has the duty and power to develop, review and recommend those
standards, limits and conditions, and




(c)

the registrant has successfully completed a certification program
established, required or approved under the bylaws to ensure
registrants are qualified and competent to perform the activity.




(2)

A registrant may dispense a drug for use in providing the service of
medical assistance in dying only in accordance with the standards,
limits and conditions established by the board for the dispensing of a
drug for that use.


[en. B.C. Reg. 234/2009, s. 3; am. B.C. Regs. 201/2016, Sch. 2, s. 2;
111/2023, App. 1, s. 4.]






Patient relations program




5


The college is designated for the purposes of section 16 (2) (f) of
the Act.




Schedule A

[en. B. C. Reg. 111/2023, App. 1, s. 5.]

(section 4)






Column 1

Disease, disorder or condition




Column 2

Drug category




Acne
Topical drugs


Allergic rhinitis

Intranasal drugs, including antihistamine drugs

Ophthalmic drugs, including antihistamine drugs

Oral antihistamine drugs




Conjunctivitis (allergic, bacterial or viral)

Ophthalmic drugs



Dermatitis (allergic, atopic, contact, diaper or seborrheic)

Topical drugs


Dysmenorrhea

Non-steroidal anti-inflammatory drugs



Dyspepsia

Gastric acid-reducing drugs




Fungal infections (Onychomycosis, Tinea corporis infection, Tinea
cruris infection or Tinea pedis infection)

Topical drugs



Gastroesophageal reflux disease


Gastric acid-reducing drugs



Headache

Non-steroidal anti-inflammatory drugs



Hemorrhoids
Topical drugs


Herpes labialis

Topical drugs, including antiviral drugs

Other types of antiviral drugs



Impetigo
Topical drugs


Musculoskeletal pain

Non-steroidal anti-inflammatory drugs



Nicotine dependence

Nicotine cessation drugs




Oral ulcers (canker sores or aphthous ulcers)

Topical drugs



Oropharyngeal candidiasis

Antifungal drugs


Shingles
Antiviral drugs



Threadworms or pinworms

Anthelmintic drugs



Urinary tract infection (uncomplicated)

Antibiotic drugs



Urticaria, including insect bites


Topical drugs, including antihistamine drugs

Other types of antihistamine drugs



Vaginal candidiasis
Antifungal drugs




[Provisions relevant to the enactment of this regulation:

Health Professions Act

, R.S.B.C. 1996, c. 183, s. 12 (2).]



